ATE266415T1 - Behandlung von dilatierte kardiomyopathie durch entfernung von autoantikoerpern - Google Patents
Behandlung von dilatierte kardiomyopathie durch entfernung von autoantikoerpernInfo
- Publication number
- ATE266415T1 ATE266415T1 AT96941378T AT96941378T ATE266415T1 AT E266415 T1 ATE266415 T1 AT E266415T1 AT 96941378 T AT96941378 T AT 96941378T AT 96941378 T AT96941378 T AT 96941378T AT E266415 T1 ATE266415 T1 AT E266415T1
- Authority
- AT
- Austria
- Prior art keywords
- patient
- treatment
- column
- immunoapheresis
- pressure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
- B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55926295A | 1995-11-15 | 1995-11-15 | |
PCT/US1996/018457 WO1997017980A1 (en) | 1995-11-15 | 1996-11-15 | Treatment of cardiomyopathy by removal of autoantibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE266415T1 true ATE266415T1 (de) | 2004-05-15 |
Family
ID=24232937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96941378T ATE266415T1 (de) | 1995-11-15 | 1996-11-15 | Behandlung von dilatierte kardiomyopathie durch entfernung von autoantikoerpern |
Country Status (7)
Country | Link |
---|---|
US (1) | US7022322B2 (de) |
EP (1) | EP0862444B2 (de) |
JP (1) | JP2002504831A (de) |
AT (1) | ATE266415T1 (de) |
AU (1) | AU731452B2 (de) |
DE (1) | DE69632476T3 (de) |
WO (1) | WO1997017980A1 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6620382B1 (en) | 1998-05-22 | 2003-09-16 | Biopheresis Technologies, Llc. | Method and compositions for treatment of cancers |
US8197430B1 (en) | 1998-05-22 | 2012-06-12 | Biopheresis Technologies, Inc. | Method and system to remove cytokine inhibitor in patients |
US6406861B1 (en) * | 1998-10-07 | 2002-06-18 | Cell Genesys, Inc. | Methods of enhancing effectiveness of therapeutic viral immunogenic agent administration |
US6464976B1 (en) * | 1999-09-07 | 2002-10-15 | Canji, Inc. | Methods and compositions for reducing immune response |
US6379708B1 (en) * | 1999-11-20 | 2002-04-30 | Cytologic, Llc | Method for enhancing immune responses in mammals |
US8609436B2 (en) | 2000-03-17 | 2013-12-17 | Guy's & St Thomas' Hospital NHS Trust (“GST”) | Method |
US8088586B2 (en) * | 2000-03-17 | 2012-01-03 | Oxford Radcliffe Hospital Nhs Trust | Method of producing a body fluid sample depleted of anti-MHC antibodies |
JP4541490B2 (ja) * | 2000-04-07 | 2010-09-08 | 株式会社カネカ | 拡張型心筋症用吸着体 |
WO2003012396A2 (en) | 2001-08-01 | 2003-02-13 | Chauhan Anil K | Immune complexes |
PT1949915E (pt) * | 2004-04-30 | 2012-11-27 | Biopheresis Technologies Inc | Método e sistema para remover rfnt1,rfnt2, e ril2 solúveis em pacientes |
US8034785B2 (en) | 2004-10-28 | 2011-10-11 | Kaneka Corporation | Adsorbent adsorbing antibody against β1 adrenoreceptor |
US20070065514A1 (en) * | 2005-09-22 | 2007-03-22 | Howell Mark D | Method for enhancing immune responses in mammals |
EP1832600A1 (de) * | 2006-03-09 | 2007-09-12 | Max-Delbrück-Centrum Für Molekulare Medizin | Peptide gegen Autoantikörper verbunden mit Glaukom und deren Verwendung |
DE102006042012A1 (de) * | 2006-09-07 | 2008-03-27 | Fresenius Medical Care Deutschland Gmbh | Verfahren zur Unterstützung von Immuntherapien |
US20080075690A1 (en) * | 2006-09-22 | 2008-03-27 | Mark Douglas Howell | Method for enhancing immune responses in mammals |
JPWO2008099855A1 (ja) * | 2007-02-14 | 2010-05-27 | 旭化成クラレメディカル株式会社 | 自己抗体吸着材 |
US7601689B2 (en) * | 2007-04-12 | 2009-10-13 | Naidu Lp | Angiogenin complexes (ANGex) and uses thereof |
US8420330B2 (en) * | 2011-07-15 | 2013-04-16 | Myra A. Lipes | Diagnosis and treatment of cardiac troponin 1 (cTn1) autoantibody-mediated heart disease |
JP5429804B2 (ja) * | 2007-09-26 | 2014-02-26 | 独立行政法人国立循環器病研究センター | 体内に存在する病因物質の低下剤 |
EP2110140A1 (de) * | 2008-04-18 | 2009-10-21 | Gert Baumann | Behandlung von Thromboangiitis obliterans mittels Autoantikörperentfernung |
KR20100041277A (ko) * | 2008-10-13 | 2010-04-22 | 재단법인서울대학교산학협력재단 | 응집핵이 결합된 고분자 지지체 |
EP3110317B1 (de) | 2014-02-25 | 2023-05-03 | ICU Medical, Inc. | Patientenüberwachungssystem mit gatekeeper-signal und entsprechendes verfahren |
CA3002372C (en) | 2015-10-19 | 2021-03-02 | Icu Medical, Inc. | Hemodynamic monitoring system with detachable display unit |
EP3607978A1 (de) * | 2018-08-06 | 2020-02-12 | Pentracor GmbH | Vereinfachte regeneration von apheresesäulen |
WO2022020569A1 (en) * | 2020-07-22 | 2022-01-27 | The Rockefeller University | Type 1 ifn assays and methods of diagnosis for susceptibility to and treatment of viral disease and viral vaccines, including covid-19 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4223672A (en) * | 1979-02-08 | 1980-09-23 | Baxter Travenol Laboratories, Inc. | Variable volume plasma treatment chamber for an apparatus for the extracorporeal treatment of disease |
US4681870A (en) * | 1985-01-11 | 1987-07-21 | Imre Corporation | Protein A-silica immunoadsorbent and process for its production |
WO1991017171A1 (en) * | 1990-05-07 | 1991-11-14 | Oklahoma Medical Research Foundation | NUCLEOTIDE SEQUENCE ENCODING A 52 kDa Ro/SSA AUTOANTIGEN |
JPH06508030A (ja) * | 1991-05-15 | 1994-09-14 | ザイモジェネティクス,インコーポレイティド | ヒトすい島グルタミン酸デカルボキシラーゼ自己抗原のクローニング及び発現 |
US5295953A (en) * | 1992-05-26 | 1994-03-22 | Hemagen/Pfc | Method and apparatus for extracorporeal separation of fluorochemicals from whole blood of a patient |
WO1995031727A1 (en) * | 1994-05-13 | 1995-11-23 | Therasorb Medizinische Systeme Gmbh | Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood |
-
1996
- 1996-11-15 JP JP51913897A patent/JP2002504831A/ja active Pending
- 1996-11-15 WO PCT/US1996/018457 patent/WO1997017980A1/en active IP Right Grant
- 1996-11-15 DE DE69632476.8T patent/DE69632476T3/de not_active Expired - Lifetime
- 1996-11-15 AU AU10540/97A patent/AU731452B2/en not_active Expired
- 1996-11-15 AT AT96941378T patent/ATE266415T1/de not_active IP Right Cessation
- 1996-11-15 EP EP96941378.0A patent/EP0862444B2/de not_active Expired - Lifetime
-
2002
- 2002-11-19 US US10/299,940 patent/US7022322B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0862444B2 (de) | 2014-04-09 |
WO1997017980A1 (en) | 1997-05-22 |
JP2002504831A (ja) | 2002-02-12 |
EP0862444A1 (de) | 1998-09-09 |
AU731452B2 (en) | 2001-03-29 |
US20030125657A1 (en) | 2003-07-03 |
DE69632476T2 (de) | 2005-05-12 |
DE69632476D1 (de) | 2004-06-17 |
DE69632476T3 (de) | 2014-05-22 |
EP0862444B1 (de) | 2004-05-12 |
US7022322B2 (en) | 2006-04-04 |
AU1054097A (en) | 1997-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE266415T1 (de) | Behandlung von dilatierte kardiomyopathie durch entfernung von autoantikoerpern | |
FR17C1062I2 (fr) | Anticorps specifiques a l' humain cd22 et leurs utilisation therapeutiques et diagnostiques | |
DE69637800D1 (de) | Verbindungen zur Behandlung der ischaemischen Gewebe | |
FR2703693B1 (fr) | Procédé rapide de détermination d'une séquence d'ADN et application au séquençage et au diagnostic. | |
ATE482234T1 (de) | Antikörper gegen kdr, deren herstellung und verwendungen | |
EA200001169A1 (ru) | Специфично связывающиеся молекулы для сцинтиграфии, содержащие их конъюгаты и терапевтический способ лечения ангиогенеза | |
DE69034261D1 (de) | Antikörper gegen VLA-4 | |
MY136603A (en) | Biological products | |
DE69535133D1 (de) | Humanisierte antikörper gegen das leukozytenadhäsionsmolekül vla-4 | |
DE69220946T2 (de) | Verwendung von nukleinsäureanaloga in diagnostischen und analytischen verfahren | |
NO982062D0 (no) | Humaniserte antistoff mot humant gp39, sammensetninger inneholdende dette, samt terapeutisk anvendelse derav | |
DK43890D0 (da) | Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse | |
ATE166230T1 (de) | Verwendung von anti-icam antikörpern zur herstellung eines präparats für die behandlung von endotoxinschock | |
BR9603826A (pt) | Processo para recuperar imunoglobulina de frações produzidas durante o fracionamento de plasma sanguíneo humano | |
ATE191502T1 (de) | Corticotropinauslösefaktor-bindendes protein | |
DE59508509D1 (de) | Dna-expressionsvektoren zur verwendung in der gentherapeutischen behandlung von gefässerkrankungen | |
CA2236598A1 (en) | Treatment of cardiomyopathy by removal of autoantibodies | |
DE69929683D1 (de) | Antisense modulierung von lfa-3 | |
DE19954305A1 (de) | Peptide des AT¶1¶-Rezeptors und ihre Verwendung, insbesondere für die Diagnostider Präeklampsie | |
WO2001032693A3 (de) | Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz | |
DE69232140D1 (de) | Die herstellung von menschlichen, monoklonalen antikörpern, die gegen das oberflächenantigen von hepatitis b aktiv sind | |
ATE205255T1 (de) | Spezifische antikörper gegen aktivierte plättchen,ihre herstellung und ihre verwendung in diagnose und therapie | |
ATE235260T1 (de) | Verfahren zum herstellen von nebenwirkungsfreien konstrastmitteln bei ultrafiltration | |
EP0338436A3 (de) | Monoklonale Antikörper gegen das Neuropeptid Y, Verfahren zu ihrer Herstellung sowie ihre Verwendung | |
RU93046224A (ru) | Способ моделирования артериальной гипертензии |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |